The system integrates Emerson’s Aspen Hybrid Models into Saudi Aramco’s refinery planning framework, enabling higher ...
Saudi Aramco has partnered with Emerson to implement AI-driven Aspen Hybrid Models across its global refining network, achieving up to 98.5% prediction accuracy in key units. The technology is ...
Emerson implements AI-driven optimisation models for Aramco, achieving up to 98.5% accuracy in refinery planning. Emerson ...
Emerson's Aspen Hybrid Models are being deployed in a bid to improve planning and operational efficiency across Aramco's ...
Fortune today announced the speaker lineup for its annual Brainstorm Tech conference, which will take place June 8–10, 2026, at the Aspen Meadows Resort in Aspen, Colorado. The first Brainstorm was ...
Srinivas Narayanan, Chief Technology Officer (CTO) of B2B Applications at OpenAI, announced Saturday that he will leave the company at the end of next week after three years. In posts on X and ...
In short: Peter Bailis, who joined Workday as chief technology officer in May 2025, left the company last month and has taken a role as member of technical staff at Anthropic, where he will focus on ...
Coronary revascularization of a chronic total occlusion (CTO) with PCI appears to significantly improve quality of life and reduce patient symptoms when compared with optimal medical therapy (OMT), ...
Aspen Snowmass has expanded its offerings of Passes for the 2026/27 winter season, with new flexibility, broader access and loyalty appreciation going live on Wednesday. While the familiar Alpine ...
Tamara Davis has been appointed chief technology officer and director of the Enterprise Technology Division for King County, Wash., after serving as interim CTO for more than a year, a move she ...
Andrew Bosworth, Meta's CTO, shared some advice for college students. He said students should be 'constantly building.' Bosworth also weighed in on a viral debate around "introspection." Andrew ...
NEW ORLEANS, LA—Treating patients with chronic total occlusions (CTOs) with PCI significantly reduces angina symptoms, according to the results of the first placebo-controlled trial in this population ...